Pharmacokinetic and bioequivalence studies of immediate release diclofenac potassium tablets (50mg) in healthy volunteers.

生物等效性 药代动力学 置信区间 医学 色谱法 双氯芬酸 药理学 高效液相色谱法 化学 内科学
作者
Huma Ali,Muhammad Harris Shoaib,Farya Zafar,Muhammad Hanif,Rabia Bushra,Asia Naz,Raheela Khursheed
出处
期刊:PubMed 卷期号:29 (5): 1671-1679 被引量:5
链接
标识
摘要

This study was conducted with the aim to determine the pharmacokinetic and bioequivalence of diclofenac potassium 50 mg test (F4) tablet formulation with reference product (Caflam). Present study was single dose, randomized, two phase cross over design, conducted in 12 healthy Pakistani volunteers and planned in accordance with FDA guidelines. In this study a simple, selective, sensitive and reproducible HPLC procedure was developed and validated for the estimation of diclofenac potassium in plasma. The process was validated in the range of 50 - 0.05 µg.mL-1 and used in bioequivalence trial of two products. Multiple blood samples were collected at various time points (0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 14 hr after treating volunteers with test (F4) and marketed reference brand. Plasma separation and deproteination were carried out with acetonitrile; samples (20µL) were injected using the validated HPLC method. Various pharmacokinetic parameters (compartmental and noncompartmental) were estimated using KineticaTM 4.4.1 (Thermo Electron Corp. USA). Bioequivalence among the products was established by calculating the 90% CI with log and non log transformed data for Cmaxcalc, Tmaxcalc, AUC0-∞, AUCtot and AUClast using two way ANOVA and Schirmann's Two one sided t- test. No significant difference was found between log and non-log data. The 90% confidence interval values using log transformed data for AUC0-∞ (0.997-1.024), AUCtot (1.004-1.031), AUClast (0.997 -1.024), Cmaxcalc (0.994-1.007) and Tmaxcalc (0.996-1.013) for the trial and reference products were found within the FDA acceptable limits of 0.8-1.25. Results were further verified by the Schirmann's one-sided t test. Results showed the bioequivalence of test and reference formulations. Both the products were well tolerated.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kttl关注了科研通微信公众号
刚刚
1秒前
wanci应助Camellia采纳,获得10
1秒前
lllllllll发布了新的文献求助10
2秒前
2秒前
lixinran完成签到,获得积分10
2秒前
耍酷问兰完成签到,获得积分10
3秒前
3秒前
bkagyin应助小小虾采纳,获得10
4秒前
4秒前
归尘发布了新的文献求助10
4秒前
小蘑菇应助俭朴的雁芙采纳,获得10
4秒前
abc123发布了新的文献求助10
5秒前
香蕉觅云应助Billy采纳,获得10
5秒前
ZQ完成签到,获得积分10
5秒前
FENGHUI完成签到,获得积分10
6秒前
毛毛发布了新的文献求助10
6秒前
wyk完成签到,获得积分10
7秒前
小蚂蚁完成签到 ,获得积分10
7秒前
晨雨初听完成签到,获得积分10
7秒前
puhui发布了新的文献求助10
8秒前
CT发布了新的文献求助10
9秒前
传奇3应助lllllllll采纳,获得10
9秒前
852应助刘步遥采纳,获得10
10秒前
FashionBoy应助lilei采纳,获得10
10秒前
淘气科研发布了新的文献求助10
10秒前
10秒前
13发布了新的文献求助10
10秒前
阳光土豆应助Whale采纳,获得10
10秒前
朋克发布了新的文献求助10
11秒前
11秒前
共享精神应助努努采纳,获得10
12秒前
章宇发布了新的文献求助10
12秒前
12秒前
14秒前
李小鑫吖发布了新的文献求助10
15秒前
15秒前
chen发布了新的文献求助10
15秒前
15秒前
英俊的铭应助思维隋采纳,获得10
16秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3979196
求助须知:如何正确求助?哪些是违规求助? 3523110
关于积分的说明 11216298
捐赠科研通 3260559
什么是DOI,文献DOI怎么找? 1800098
邀请新用户注册赠送积分活动 878823
科研通“疑难数据库(出版商)”最低求助积分说明 807092